phosphorodithioic acid has been researched along with B16 Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ager, CR; Curran, MA; Di Francesco, ME; Jones, P; Wei, Z; Zhang, H | 1 |
Altman, S; Burakova, EA; Chelobanov, BP; Fokina, AA; Miroshnichenko, SK; Patutina, OA; Stetsenko, DA; Vlassov, VV; Zenkova, MA | 1 |
Bagdon, P; Devarie-Baez, NO; Pacheco, A; Park, CM; Peng, B; Xian, M; Zhang, H; Zhao, Y; Zhu, Z | 1 |
3 other study(ies) available for phosphorodithioic acid and B16 Melanoma
Article | Year |
---|---|
Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Line; Cytosol; Heterocyclic Compounds; Humans; Immunity, Innate; Immunotherapy; Interferon-beta; Melanoma; Melanoma, Experimental; Membrane Proteins; Mice; Nucleotides, Cyclic; Phosphates; Signal Transduction; Tumor Microenvironment | 2019 |
Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties.
Topics: Amides; Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA; Melanoma, Experimental; Mice; MicroRNAs; Oligonucleotides; Oligonucleotides, Antisense; Phosphates; Phosphoric Acids; Ribonuclease H; RNA | 2019 |
Synthesis and evaluation of phosphorodithioate-based hydrogen sulfide donors.
Topics: Animals; Cell Survival; Humans; Hydrogen Sulfide; Melanoma, Experimental; Mice; Molecular Structure; Muscle Cells; Oxidative Stress; Phosphates | 2013 |